[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PCM_bio Patients Capital Management LLCPatients Capital Management LLC posts on X about $xbi, $ibb, $abbv, $bmy the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks XXXXX% finance XXXX% social networks XXXX% technology brands XXXX% currencies XXXX%
Social topic influence $xbi #7, $ibb #2, $abbv #3, $bmy #20, $abvx #8, $janx 9.52%, tiktok 9.52%, $vktx #3, put the 9.52%, $nuvb XXXX%
Top accounts mentioned or mentioned by @persimmonti @rudyresearch @tallnfat @michaelrose102 @jayg327 @ldtimmerman @savoryseaw50174 @adamfeuerstein @cal9797 @wallstsai @0xpasserby @richtrades100
Top assets mentioned Bitcoin Incognito (XBI) AbbVie Inc (ABBV) Bristol-Myers Squibb Co (BMY) Janux Therapeutics, Inc. Common Stock (JANX) Viking Therapeutics, Inc (VKTX) Eli Lilly and Company (LLY) Amgen, Inc. (AMGN) Metsera, Inc. Common Stock (MTSR) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Axsome Therapeutics, Inc (AXSM) Exact Sciences Corp (EXAS) ADMA Biologics, Inc. (ADMA) Twist Bioscience Corporation Common Stock (TWST) Moderna Inc (MRNA) Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) Synthetify (SNY) AstraZeneca PLC (AZN) Novartis AG (NVS) Gilead Sciences, Inc. (GILD) Johnson & Johnson (JNJ) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Crinetics Pharmaceuticals, Inc. (CRNX) Disc Medicine, Inc. Common Stock (IRON) Sanofi (SNY)
Top posts by engagements in the last XX hours
"@Michaelrose102 $janx been watching too many $amgn maritide and rocatinlimab update calls"
X Link 2025-12-01T21:29Z 2764 followers, 1543 engagements
"@tallnfat @RudyResearch Comment wasnt made to imply I agree with $abbv. simply an observation"
X Link 2025-12-03T19:33Z 2763 followers, XXX engagements
"$gpcr proving me wrong in turning over ACCESS data. Was very nervous going into this a.m. (also almost got stopped out) Imagine being a BP having balance sheet to deploy interest in obesity and no obesity presence and / or competitive oral option. And then imagine not chasing $gpcr. tik tok on the M&A clock $xbi $ibb"
X Link 2025-12-08T21:36Z 2781 followers, 12.9K engagements
"Post mortem: revs for Osgiveo have rebounded nicely and Gomekli off to solid start. Prob would have been a challenging name to own in 1H given the 1Q hiccup but also looks like $swtx timed their sale / going into blackout period V poorly. Good work by $MRK.DE $xbi $ibb"
X Link 2025-11-13T09:41Z 2776 followers, 2685 engagements
"Would put the likelihood that $Bmy transacts before or during JPM / adds an asset that is accretive to growth story at XXX% $xbi $ibb"
X Link 2025-11-25T17:54Z 2766 followers, 13.9K engagements
"$nuvb discontinuing 1511. coincidentql timing while they message strongly around consummating ex-US partnership for Ibtrozi Question really is why a partner would not want to own US economics (I.e. WholeCo) $xbi $ibb"
X Link 2025-11-26T16:07Z 2767 followers, 2337 engagements
"With somewhat increased optimism in AD psychosis would make a ton of sense for $bmy to double down on LTC and neuropsych with $axsm . need growth asap"
X Link 2025-12-03T14:16Z 2776 followers, 2274 engagements
"@tallnfat They XXX% can dictate combo strategies"
X Link 2025-12-03T19:00Z 2776 followers, XXX engagements
"Not my game but $janx does get interesting at $300mm EV"
X Link 2025-12-01T22:02Z 2778 followers, 6649 engagements
"Can someone explain to me why $exas $adma and $twst need to be in $xbi Its almost like its designed to be shorted"
X Link 2025-08-07T13:48Z 2781 followers, 7165 engagements
"$abbv throwing shade at $abvx today"
X Link 2025-12-03T17:44Z 2781 followers, 8918 engagements
"I dont follow. At first glance some other buyout targets that didnt use JPM on last follow-on / convert include $vktx $mdgl $ions $crnx $nuvb $rapp $iron There are probably several others. Simply pointing out there is no reason for $abvx to present and JPM would probably swallow their pride to appease investors. Plus has nothing to do with buyout as they would withdraw from presenting closer to the date By same logic some buyers that didnt use JPM on recent deals include $nvs $mrk $lly $rhhby $gsk $gmab . should we assume JPM is advising all of these parties on upcoming deals No"
X Link 2025-12-10T02:22Z 2781 followers, 1637 engagements
"Maybe its just that Dave Ricks wanted to take scenic route to Saint-Tropez offseason $lly $abvx"
X Link 2025-12-11T01:01Z 2781 followers, 4464 engagements